CAS 1096708-71-2

4-Pyrimidinecarboxamide, 6-amino-5-chloro-n-[(1r)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-

CAS: 1096708-71-2

Formel: C₁₇H₁₂Cl₂F₃N₇O₂S

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 506.2891

Ref: IN-DA008TIA

TAK-580

CAS: 1096708-71-2

TAK-580

Reinheit: ≥98%

Molekulargewicht: 506.29g/mol

Ref: 54-BUP03222

Tovorafenib

CAS: 1096708-71-2

Formel: C₁₇H₁₂Cl₂F₃N₇O₂S

Molekulargewicht: 506.29

Ref: 4Z-T-469001

TAK-580

CAS: 1096708-71-2

TAK-580 (MLN2480) is an oral, selective pan-Raf kinase inhibitor in Clinicalal trials.

Formel: C₁₇H₁₂Cl₂F₃N₇O₂S

Reinheit: 99.25% - 99.77%

Farbe und Form: Solid

Molekulargewicht: 506.29

Ref: TM-T6895

MLN2480

Kontrolliertes Produkt

CAS: 1096708-71-2

Applications MLN2480 is a RAF inhibitor that is used for the treatment of melanoma.

Formel: C₁₇H₁₂Cl₂F₃N₇O₂S

Farbe und Form: Neat

Molekulargewicht: 506.29

Ref: TR-M425140

BIIB-024

CAS: 1096708-71-2

BIIB-024 is a monoclonal antibody that targets mutant melanoma cells. It binds to the tumor and prevents it from growing, as well as preventing the cancer cells from spreading. BIIB-024 has shown effectiveness in clinical studies by reducing tumor size and skin reactions in patients with melanoma. The effective dose of BIIB-024 is 10 milligrams per kilogram of body weight. BIIB-024 also inhibits protein synthesis in tumor cells, which may be due to its ability to bind to cytosolic proteins.

Formel: C₁₇H₁₂Cl₂F₃N₇O₂S

Reinheit: Min. 95%

Molekulargewicht: 506.29 g/mol

Ref: 3D-FB103923